St. Louis University — St Louis, Missouri

St. Louis University is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

St. Louis University has participated in 107 clinical trials with 10 currently active.

Therapeutic areas: BCCs in Gorlin Syndrome Patients, Primary Sclerosing Cholangitis, Hepatocellular Carcinoma.

Sponsors: Palvella Therapeutics, Inc., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Exact Sciences Corporation.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Louis University?

St. Louis University has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Louis University conducted?

St. Louis University has 107 clinical trials on record, with 10 currently active. Their work covers BCCs in Gorlin Syndrome Patients, Primary Sclerosing Cholangitis, Hepatocellular Carcinoma.

Is St. Louis University accredited by Crixeo Health?

Yes — St. Louis University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about St. Louis University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.